Home › Psoriatic Arthritis › Missouri › Kansas City
Psoriatic Arthritis clinical trials in Kansas City, MO
4 studies for Psoriatic Arthritis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
RecruitingPhase 2
- Kansas City Physician Partners ( Site 5119), Kansas City
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
RecruitingPhase 3
- AARR- Kansas City Physician Partners, Kansas City
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Children's Mercy Hospital, Kansas City
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX8 studies
- Charlotte, NC7 studies
- Altoona, PA6 studies
- Parma, OH6 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Plantation, FL5 studies
- Cleveland, OH5 studies
- Clearwater, FL5 studies
- New York City, NY5 studies
- Milwaukee, WI5 studies
- San Diego, CA5 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.